nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—CYP2E1—Dacarbazine—pancreatic cancer	0.171	0.232	CbGbCtD
Meprobamate—CYP2E1—Tamoxifen—pancreatic cancer	0.136	0.184	CbGbCtD
Meprobamate—CYP2C19—Tamoxifen—pancreatic cancer	0.0851	0.116	CbGbCtD
Meprobamate—ABCB1—Tamoxifen—pancreatic cancer	0.0687	0.0932	CbGbCtD
Meprobamate—ABCB1—Gemcitabine—pancreatic cancer	0.0592	0.0803	CbGbCtD
Meprobamate—ABCB1—Erlotinib—pancreatic cancer	0.0584	0.0793	CbGbCtD
Meprobamate—ABCB1—Irinotecan—pancreatic cancer	0.0527	0.0716	CbGbCtD
Meprobamate—ABCB1—Docetaxel—pancreatic cancer	0.0386	0.0525	CbGbCtD
Meprobamate—ABCB1—Sunitinib—pancreatic cancer	0.0385	0.0522	CbGbCtD
Meprobamate—ABCB1—Doxorubicin—pancreatic cancer	0.0288	0.0391	CbGbCtD
Meprobamate—Proctitis—Fluorouracil—pancreatic cancer	0.0106	0.0403	CcSEcCtD
Meprobamate—Slurred speech—Fluorouracil—pancreatic cancer	0.0058	0.022	CcSEcCtD
Meprobamate—Proctitis—Epirubicin—pancreatic cancer	0.00517	0.0196	CcSEcCtD
Meprobamate—Proctitis—Doxorubicin—pancreatic cancer	0.00479	0.0182	CcSEcCtD
Meprobamate—Anuria—Epirubicin—pancreatic cancer	0.00361	0.0137	CcSEcCtD
Meprobamate—Anuria—Doxorubicin—pancreatic cancer	0.00334	0.0127	CcSEcCtD
Meprobamate—Petechiae—Gemcitabine—pancreatic cancer	0.00321	0.0122	CcSEcCtD
Meprobamate—Rash maculo-papular—Sunitinib—pancreatic cancer	0.00299	0.0113	CcSEcCtD
Meprobamate—Dermatitis bullous—Tamoxifen—pancreatic cancer	0.00292	0.0111	CcSEcCtD
Meprobamate—Dermatitis bullous—Erlotinib—pancreatic cancer	0.00288	0.0109	CcSEcCtD
Meprobamate—Dysarthria—Irinotecan—pancreatic cancer	0.00286	0.0109	CcSEcCtD
Meprobamate—Dysarthria—Fluorouracil—pancreatic cancer	0.00274	0.0104	CcSEcCtD
Meprobamate—Dermatitis bullous—Sunitinib—pancreatic cancer	0.0025	0.00948	CcSEcCtD
Meprobamate—Rash maculo-papular—Fluorouracil—pancreatic cancer	0.00236	0.00895	CcSEcCtD
Meprobamate—Euphoric mood—Fluorouracil—pancreatic cancer	0.00223	0.00846	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.00213	0.00808	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.00211	0.008	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Irinotecan—pancreatic cancer	0.00208	0.00791	CcSEcCtD
Meprobamate—Stomatitis—Erlotinib—pancreatic cancer	0.00207	0.00786	CcSEcCtD
Meprobamate—Oliguria—Docetaxel—pancreatic cancer	0.00203	0.00771	CcSEcCtD
Meprobamate—Dermatitis bullous—Gemcitabine—pancreatic cancer	0.002	0.00761	CcSEcCtD
Meprobamate—Dermatitis bullous—Fluorouracil—pancreatic cancer	0.00197	0.00748	CcSEcCtD
Meprobamate—Oedema peripheral—Tamoxifen—pancreatic cancer	0.0019	0.00721	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00182	0.00692	CcSEcCtD
Meprobamate—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00182	0.00692	CcSEcCtD
Meprobamate—Erythema multiforme—Erlotinib—pancreatic cancer	0.0018	0.00685	CcSEcCtD
Meprobamate—Stomatitis—Sunitinib—pancreatic cancer	0.00179	0.0068	CcSEcCtD
Meprobamate—Ataxia—Fluorouracil—pancreatic cancer	0.00177	0.00672	CcSEcCtD
Meprobamate—Arrhythmia—Tamoxifen—pancreatic cancer	0.00172	0.00654	CcSEcCtD
Meprobamate—Chills—Erlotinib—pancreatic cancer	0.00171	0.0065	CcSEcCtD
Meprobamate—Arrhythmia—Erlotinib—pancreatic cancer	0.0017	0.00647	CcSEcCtD
Meprobamate—Bronchospasm—Gemcitabine—pancreatic cancer	0.00163	0.00618	CcSEcCtD
Meprobamate—Oedema peripheral—Sunitinib—pancreatic cancer	0.00163	0.00617	CcSEcCtD
Meprobamate—Eosinophilia—Fluorouracil—pancreatic cancer	0.00161	0.00612	CcSEcCtD
Meprobamate—Erythema multiforme—Sunitinib—pancreatic cancer	0.00156	0.00593	CcSEcCtD
Meprobamate—Petechiae—Epirubicin—pancreatic cancer	0.00153	0.00583	CcSEcCtD
Meprobamate—Angioedema—Tamoxifen—pancreatic cancer	0.00153	0.00582	CcSEcCtD
Meprobamate—Leukopenia—Tamoxifen—pancreatic cancer	0.0015	0.0057	CcSEcCtD
Meprobamate—Syncope—Erlotinib—pancreatic cancer	0.00149	0.00565	CcSEcCtD
Meprobamate—Chills—Sunitinib—pancreatic cancer	0.00148	0.00562	CcSEcCtD
Meprobamate—Stomatitis—Irinotecan—pancreatic cancer	0.00148	0.00561	CcSEcCtD
Meprobamate—Arrhythmia—Sunitinib—pancreatic cancer	0.00147	0.0056	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00146	0.00555	CcSEcCtD
Meprobamate—Loss of consciousness—Erlotinib—pancreatic cancer	0.00146	0.00554	CcSEcCtD
Meprobamate—Stomatitis—Gemcitabine—pancreatic cancer	0.00144	0.00546	CcSEcCtD
Meprobamate—Dermatitis bullous—Docetaxel—pancreatic cancer	0.00142	0.0054	CcSEcCtD
Meprobamate—Petechiae—Doxorubicin—pancreatic cancer	0.00142	0.00539	CcSEcCtD
Meprobamate—Stomatitis—Fluorouracil—pancreatic cancer	0.00141	0.00537	CcSEcCtD
Meprobamate—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00138	0.00523	CcSEcCtD
Meprobamate—Oliguria—Epirubicin—pancreatic cancer	0.00137	0.0052	CcSEcCtD
Meprobamate—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00135	0.00514	CcSEcCtD
Meprobamate—Dysarthria—Epirubicin—pancreatic cancer	0.00134	0.00507	CcSEcCtD
Meprobamate—Shock—Erlotinib—pancreatic cancer	0.00133	0.00506	CcSEcCtD
Meprobamate—Angioedema—Sunitinib—pancreatic cancer	0.00131	0.00498	CcSEcCtD
Meprobamate—Oedema peripheral—Gemcitabine—pancreatic cancer	0.00131	0.00495	CcSEcCtD
Meprobamate—Leukopenia—Sunitinib—pancreatic cancer	0.00129	0.00488	CcSEcCtD
Meprobamate—Ataxia—Docetaxel—pancreatic cancer	0.00128	0.00485	CcSEcCtD
Meprobamate—Oliguria—Doxorubicin—pancreatic cancer	0.00127	0.00481	CcSEcCtD
Meprobamate—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00125	0.00475	CcSEcCtD
Meprobamate—Dysarthria—Doxorubicin—pancreatic cancer	0.00124	0.00469	CcSEcCtD
Meprobamate—Paraesthesia—Tamoxifen—pancreatic cancer	0.00123	0.00467	CcSEcCtD
Meprobamate—Chills—Irinotecan—pancreatic cancer	0.00122	0.00463	CcSEcCtD
Meprobamate—Arrhythmia—Irinotecan—pancreatic cancer	0.00121	0.00461	CcSEcCtD
Meprobamate—Chills—Gemcitabine—pancreatic cancer	0.00119	0.00451	CcSEcCtD
Meprobamate—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00119	0.0045	CcSEcCtD
Meprobamate—Arrhythmia—Gemcitabine—pancreatic cancer	0.00118	0.00449	CcSEcCtD
Meprobamate—Arrhythmia—Fluorouracil—pancreatic cancer	0.00116	0.00442	CcSEcCtD
Meprobamate—Bronchospasm—Docetaxel—pancreatic cancer	0.00116	0.00439	CcSEcCtD
Meprobamate—Shock—Sunitinib—pancreatic cancer	0.00115	0.00438	CcSEcCtD
Meprobamate—Rash maculo-papular—Epirubicin—pancreatic cancer	0.00115	0.00436	CcSEcCtD
Meprobamate—Ecchymosis—Epirubicin—pancreatic cancer	0.00114	0.00433	CcSEcCtD
Meprobamate—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.0011	0.00416	CcSEcCtD
Meprobamate—Lymphadenopathy—Epirubicin—pancreatic cancer	0.00107	0.00408	CcSEcCtD
Meprobamate—Body temperature increased—Erlotinib—pancreatic cancer	0.00107	0.00407	CcSEcCtD
Meprobamate—Vertigo—Irinotecan—pancreatic cancer	0.00106	0.00404	CcSEcCtD
Meprobamate—Rash maculo-papular—Doxorubicin—pancreatic cancer	0.00106	0.00403	CcSEcCtD
Meprobamate—Syncope—Irinotecan—pancreatic cancer	0.00106	0.00403	CcSEcCtD
Meprobamate—Leukopenia—Irinotecan—pancreatic cancer	0.00106	0.00402	CcSEcCtD
Meprobamate—Ecchymosis—Doxorubicin—pancreatic cancer	0.00106	0.00401	CcSEcCtD
Meprobamate—Paraesthesia—Sunitinib—pancreatic cancer	0.00105	0.004	CcSEcCtD
Meprobamate—Loss of consciousness—Irinotecan—pancreatic cancer	0.00104	0.00395	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00104	0.00394	CcSEcCtD
Meprobamate—Leukopenia—Gemcitabine—pancreatic cancer	0.00103	0.00392	CcSEcCtD
Meprobamate—Vascular purpura—Epirubicin—pancreatic cancer	0.00102	0.00389	CcSEcCtD
Meprobamate—Stomatitis—Docetaxel—pancreatic cancer	0.00102	0.00387	CcSEcCtD
Meprobamate—Leukopenia—Fluorouracil—pancreatic cancer	0.00102	0.00385	CcSEcCtD
Meprobamate—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00101	0.00383	CcSEcCtD
Meprobamate—Lymphadenopathy—Doxorubicin—pancreatic cancer	0.000994	0.00377	CcSEcCtD
Meprobamate—Asthenia—Tamoxifen—pancreatic cancer	0.000983	0.00373	CcSEcCtD
Meprobamate—Agranulocytosis—Docetaxel—pancreatic cancer	0.000977	0.00371	CcSEcCtD
Meprobamate—Asthenia—Erlotinib—pancreatic cancer	0.000972	0.00369	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000971	0.00369	CcSEcCtD
Meprobamate—Pruritus—Tamoxifen—pancreatic cancer	0.000969	0.00368	CcSEcCtD
Meprobamate—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000966	0.00367	CcSEcCtD
Meprobamate—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000959	0.00364	CcSEcCtD
Meprobamate—Pruritus—Erlotinib—pancreatic cancer	0.000959	0.00364	CcSEcCtD
Meprobamate—Purpura—Epirubicin—pancreatic cancer	0.000951	0.00361	CcSEcCtD
Meprobamate—Shock—Irinotecan—pancreatic cancer	0.000951	0.00361	CcSEcCtD
Meprobamate—Vascular purpura—Doxorubicin—pancreatic cancer	0.000948	0.0036	CcSEcCtD
Meprobamate—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000941	0.00357	CcSEcCtD
Meprobamate—Diarrhoea—Tamoxifen—pancreatic cancer	0.000937	0.00356	CcSEcCtD
Meprobamate—Body temperature increased—Sunitinib—pancreatic cancer	0.000927	0.00352	CcSEcCtD
Meprobamate—Diarrhoea—Erlotinib—pancreatic cancer	0.000927	0.00352	CcSEcCtD
Meprobamate—Oedema peripheral—Docetaxel—pancreatic cancer	0.000926	0.00352	CcSEcCtD
Meprobamate—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000925	0.00351	CcSEcCtD
Meprobamate—Dizziness—Tamoxifen—pancreatic cancer	0.000906	0.00344	CcSEcCtD
Meprobamate—Tachycardia—Fluorouracil—pancreatic cancer	0.000903	0.00343	CcSEcCtD
Meprobamate—Hypotension—Irinotecan—pancreatic cancer	0.000903	0.00343	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000899	0.00341	CcSEcCtD
Meprobamate—Dizziness—Erlotinib—pancreatic cancer	0.000896	0.0034	CcSEcCtD
Meprobamate—Erythema multiforme—Docetaxel—pancreatic cancer	0.000889	0.00337	CcSEcCtD
Meprobamate—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000887	0.00337	CcSEcCtD
Meprobamate—Purpura—Doxorubicin—pancreatic cancer	0.00088	0.00334	CcSEcCtD
Meprobamate—Hypotension—Gemcitabine—pancreatic cancer	0.00088	0.00334	CcSEcCtD
Meprobamate—Vomiting—Tamoxifen—pancreatic cancer	0.000871	0.00331	CcSEcCtD
Meprobamate—Paraesthesia—Irinotecan—pancreatic cancer	0.000868	0.00329	CcSEcCtD
Meprobamate—Hypotension—Fluorouracil—pancreatic cancer	0.000865	0.00328	CcSEcCtD
Meprobamate—Hypersensitivity—Sunitinib—pancreatic cancer	0.000864	0.00328	CcSEcCtD
Meprobamate—Dermatitis—Tamoxifen—pancreatic cancer	0.000863	0.00327	CcSEcCtD
Meprobamate—Ataxia—Epirubicin—pancreatic cancer	0.000862	0.00327	CcSEcCtD
Meprobamate—Vomiting—Erlotinib—pancreatic cancer	0.000862	0.00327	CcSEcCtD
Meprobamate—Somnolence—Irinotecan—pancreatic cancer	0.000859	0.00326	CcSEcCtD
Meprobamate—Headache—Tamoxifen—pancreatic cancer	0.000858	0.00326	CcSEcCtD
Meprobamate—Dermatitis—Erlotinib—pancreatic cancer	0.000854	0.00324	CcSEcCtD
Meprobamate—Headache—Erlotinib—pancreatic cancer	0.000849	0.00322	CcSEcCtD
Meprobamate—Paraesthesia—Gemcitabine—pancreatic cancer	0.000845	0.00321	CcSEcCtD
Meprobamate—Chills—Docetaxel—pancreatic cancer	0.000844	0.0032	CcSEcCtD
Meprobamate—Asthenia—Sunitinib—pancreatic cancer	0.000842	0.00319	CcSEcCtD
Meprobamate—Arrhythmia—Docetaxel—pancreatic cancer	0.00084	0.00319	CcSEcCtD
Meprobamate—Somnolence—Gemcitabine—pancreatic cancer	0.000837	0.00318	CcSEcCtD
Meprobamate—Paraesthesia—Fluorouracil—pancreatic cancer	0.000831	0.00315	CcSEcCtD
Meprobamate—Pruritus—Sunitinib—pancreatic cancer	0.00083	0.00315	CcSEcCtD
Meprobamate—Somnolence—Fluorouracil—pancreatic cancer	0.000823	0.00312	CcSEcCtD
Meprobamate—Nausea—Tamoxifen—pancreatic cancer	0.000814	0.00309	CcSEcCtD
Meprobamate—Nausea—Erlotinib—pancreatic cancer	0.000805	0.00306	CcSEcCtD
Meprobamate—Diarrhoea—Sunitinib—pancreatic cancer	0.000803	0.00305	CcSEcCtD
Meprobamate—Ataxia—Doxorubicin—pancreatic cancer	0.000798	0.00303	CcSEcCtD
Meprobamate—Eosinophilia—Epirubicin—pancreatic cancer	0.000784	0.00298	CcSEcCtD
Meprobamate—Dizziness—Sunitinib—pancreatic cancer	0.000776	0.00294	CcSEcCtD
Meprobamate—Body temperature increased—Irinotecan—pancreatic cancer	0.000764	0.0029	CcSEcCtD
Meprobamate—Vomiting—Sunitinib—pancreatic cancer	0.000746	0.00283	CcSEcCtD
Meprobamate—Body temperature increased—Gemcitabine—pancreatic cancer	0.000744	0.00282	CcSEcCtD
Meprobamate—Dermatitis—Sunitinib—pancreatic cancer	0.000739	0.0028	CcSEcCtD
Meprobamate—Headache—Sunitinib—pancreatic cancer	0.000735	0.00279	CcSEcCtD
Meprobamate—Syncope—Docetaxel—pancreatic cancer	0.000734	0.00279	CcSEcCtD
Meprobamate—Leukopenia—Docetaxel—pancreatic cancer	0.000733	0.00278	CcSEcCtD
Meprobamate—Body temperature increased—Fluorouracil—pancreatic cancer	0.000732	0.00278	CcSEcCtD
Meprobamate—Eosinophilia—Doxorubicin—pancreatic cancer	0.000726	0.00275	CcSEcCtD
Meprobamate—Palpitations—Docetaxel—pancreatic cancer	0.000723	0.00275	CcSEcCtD
Meprobamate—Loss of consciousness—Docetaxel—pancreatic cancer	0.000719	0.00273	CcSEcCtD
Meprobamate—Hypersensitivity—Irinotecan—pancreatic cancer	0.000712	0.0027	CcSEcCtD
Meprobamate—Drowsiness—Epirubicin—pancreatic cancer	0.000706	0.00268	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.0007	0.00266	CcSEcCtD
Meprobamate—Nausea—Sunitinib—pancreatic cancer	0.000697	0.00264	CcSEcCtD
Meprobamate—Asthenia—Irinotecan—pancreatic cancer	0.000693	0.00263	CcSEcCtD
Meprobamate—Stomatitis—Epirubicin—pancreatic cancer	0.000689	0.00261	CcSEcCtD
Meprobamate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000682	0.00259	CcSEcCtD
Meprobamate—Asthenia—Gemcitabine—pancreatic cancer	0.000675	0.00256	CcSEcCtD
Meprobamate—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000668	0.00254	CcSEcCtD
Meprobamate—Pruritus—Gemcitabine—pancreatic cancer	0.000666	0.00253	CcSEcCtD
Meprobamate—Diarrhoea—Irinotecan—pancreatic cancer	0.000661	0.00251	CcSEcCtD
Meprobamate—Agranulocytosis—Epirubicin—pancreatic cancer	0.000659	0.0025	CcSEcCtD
Meprobamate—Shock—Docetaxel—pancreatic cancer	0.000657	0.00249	CcSEcCtD
Meprobamate—Pruritus—Fluorouracil—pancreatic cancer	0.000655	0.00249	CcSEcCtD
Meprobamate—Drowsiness—Doxorubicin—pancreatic cancer	0.000654	0.00248	CcSEcCtD
Meprobamate—Tachycardia—Docetaxel—pancreatic cancer	0.000652	0.00247	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000648	0.00246	CcSEcCtD
Meprobamate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000644	0.00244	CcSEcCtD
Meprobamate—Dizziness—Irinotecan—pancreatic cancer	0.000639	0.00243	CcSEcCtD
Meprobamate—Stomatitis—Doxorubicin—pancreatic cancer	0.000637	0.00242	CcSEcCtD
Meprobamate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000633	0.0024	CcSEcCtD
Meprobamate—Oedema peripheral—Epirubicin—pancreatic cancer	0.000625	0.00237	CcSEcCtD
Meprobamate—Hypotension—Docetaxel—pancreatic cancer	0.000624	0.00237	CcSEcCtD
Meprobamate—Vomiting—Irinotecan—pancreatic cancer	0.000614	0.00233	CcSEcCtD
Meprobamate—Dizziness—Fluorouracil—pancreatic cancer	0.000612	0.00232	CcSEcCtD
Meprobamate—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00061	0.00232	CcSEcCtD
Meprobamate—Dermatitis—Irinotecan—pancreatic cancer	0.000609	0.00231	CcSEcCtD
Meprobamate—Headache—Irinotecan—pancreatic cancer	0.000605	0.0023	CcSEcCtD
Meprobamate—Paraesthesia—Docetaxel—pancreatic cancer	0.0006	0.00228	CcSEcCtD
Meprobamate—Erythema multiforme—Epirubicin—pancreatic cancer	0.0006	0.00228	CcSEcCtD
Meprobamate—Vomiting—Gemcitabine—pancreatic cancer	0.000598	0.00227	CcSEcCtD
Meprobamate—Somnolence—Docetaxel—pancreatic cancer	0.000594	0.00225	CcSEcCtD
Meprobamate—Dermatitis—Gemcitabine—pancreatic cancer	0.000593	0.00225	CcSEcCtD
Meprobamate—Headache—Gemcitabine—pancreatic cancer	0.00059	0.00224	CcSEcCtD
Meprobamate—Vomiting—Fluorouracil—pancreatic cancer	0.000588	0.00223	CcSEcCtD
Meprobamate—Dermatitis—Fluorouracil—pancreatic cancer	0.000583	0.00221	CcSEcCtD
Meprobamate—Headache—Fluorouracil—pancreatic cancer	0.00058	0.0022	CcSEcCtD
Meprobamate—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000578	0.00219	CcSEcCtD
Meprobamate—Nausea—Irinotecan—pancreatic cancer	0.000574	0.00218	CcSEcCtD
Meprobamate—Chills—Epirubicin—pancreatic cancer	0.000569	0.00216	CcSEcCtD
Meprobamate—Arrhythmia—Epirubicin—pancreatic cancer	0.000566	0.00215	CcSEcCtD
Meprobamate—Nausea—Gemcitabine—pancreatic cancer	0.000559	0.00212	CcSEcCtD
Meprobamate—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000555	0.00211	CcSEcCtD
Meprobamate—Nausea—Fluorouracil—pancreatic cancer	0.00055	0.00209	CcSEcCtD
Meprobamate—Body temperature increased—Docetaxel—pancreatic cancer	0.000528	0.002	CcSEcCtD
Meprobamate—Chills—Doxorubicin—pancreatic cancer	0.000526	0.002	CcSEcCtD
Meprobamate—Arrhythmia—Doxorubicin—pancreatic cancer	0.000524	0.00199	CcSEcCtD
Meprobamate—Agitation—Epirubicin—pancreatic cancer	0.000507	0.00193	CcSEcCtD
Meprobamate—Vertigo—Epirubicin—pancreatic cancer	0.000496	0.00188	CcSEcCtD
Meprobamate—Syncope—Epirubicin—pancreatic cancer	0.000495	0.00188	CcSEcCtD
Meprobamate—Leukopenia—Epirubicin—pancreatic cancer	0.000494	0.00188	CcSEcCtD
Meprobamate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000492	0.00187	CcSEcCtD
Meprobamate—Palpitations—Epirubicin—pancreatic cancer	0.000488	0.00185	CcSEcCtD
Meprobamate—Loss of consciousness—Epirubicin—pancreatic cancer	0.000485	0.00184	CcSEcCtD
Meprobamate—Asthenia—Docetaxel—pancreatic cancer	0.000479	0.00182	CcSEcCtD
Meprobamate—Pruritus—Docetaxel—pancreatic cancer	0.000473	0.00179	CcSEcCtD
Meprobamate—Agitation—Doxorubicin—pancreatic cancer	0.000469	0.00178	CcSEcCtD
Meprobamate—Vertigo—Doxorubicin—pancreatic cancer	0.000459	0.00174	CcSEcCtD
Meprobamate—Syncope—Doxorubicin—pancreatic cancer	0.000458	0.00174	CcSEcCtD
Meprobamate—Leukopenia—Doxorubicin—pancreatic cancer	0.000457	0.00174	CcSEcCtD
Meprobamate—Diarrhoea—Docetaxel—pancreatic cancer	0.000457	0.00173	CcSEcCtD
Meprobamate—Palpitations—Doxorubicin—pancreatic cancer	0.000451	0.00171	CcSEcCtD
Meprobamate—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000451	0.00171	CcSEcCtD
Meprobamate—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000449	0.0017	CcSEcCtD
Meprobamate—Shock—Epirubicin—pancreatic cancer	0.000443	0.00168	CcSEcCtD
Meprobamate—Dizziness—Docetaxel—pancreatic cancer	0.000442	0.00168	CcSEcCtD
Meprobamate—Tachycardia—Epirubicin—pancreatic cancer	0.00044	0.00167	CcSEcCtD
Meprobamate—Vomiting—Docetaxel—pancreatic cancer	0.000425	0.00161	CcSEcCtD
Meprobamate—Hypotension—Epirubicin—pancreatic cancer	0.000421	0.0016	CcSEcCtD
Meprobamate—Dermatitis—Docetaxel—pancreatic cancer	0.000421	0.0016	CcSEcCtD
Meprobamate—Headache—Docetaxel—pancreatic cancer	0.000418	0.00159	CcSEcCtD
Meprobamate—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000417	0.00158	CcSEcCtD
Meprobamate—Shock—Doxorubicin—pancreatic cancer	0.00041	0.00156	CcSEcCtD
Meprobamate—Tachycardia—Doxorubicin—pancreatic cancer	0.000407	0.00154	CcSEcCtD
Meprobamate—Paraesthesia—Epirubicin—pancreatic cancer	0.000405	0.00154	CcSEcCtD
Meprobamate—Somnolence—Epirubicin—pancreatic cancer	0.000401	0.00152	CcSEcCtD
Meprobamate—Nausea—Docetaxel—pancreatic cancer	0.000397	0.00151	CcSEcCtD
Meprobamate—Hypotension—Doxorubicin—pancreatic cancer	0.00039	0.00148	CcSEcCtD
Meprobamate—Paraesthesia—Doxorubicin—pancreatic cancer	0.000374	0.00142	CcSEcCtD
Meprobamate—Somnolence—Doxorubicin—pancreatic cancer	0.000371	0.00141	CcSEcCtD
Meprobamate—Body temperature increased—Epirubicin—pancreatic cancer	0.000356	0.00135	CcSEcCtD
Meprobamate—Hypersensitivity—Epirubicin—pancreatic cancer	0.000332	0.00126	CcSEcCtD
Meprobamate—Body temperature increased—Doxorubicin—pancreatic cancer	0.00033	0.00125	CcSEcCtD
Meprobamate—Asthenia—Epirubicin—pancreatic cancer	0.000323	0.00123	CcSEcCtD
Meprobamate—Pruritus—Epirubicin—pancreatic cancer	0.000319	0.00121	CcSEcCtD
Meprobamate—Diarrhoea—Epirubicin—pancreatic cancer	0.000308	0.00117	CcSEcCtD
Meprobamate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000307	0.00117	CcSEcCtD
Meprobamate—Asthenia—Doxorubicin—pancreatic cancer	0.000299	0.00114	CcSEcCtD
Meprobamate—Dizziness—Epirubicin—pancreatic cancer	0.000298	0.00113	CcSEcCtD
Meprobamate—Pruritus—Doxorubicin—pancreatic cancer	0.000295	0.00112	CcSEcCtD
Meprobamate—Vomiting—Epirubicin—pancreatic cancer	0.000286	0.00109	CcSEcCtD
Meprobamate—Diarrhoea—Doxorubicin—pancreatic cancer	0.000285	0.00108	CcSEcCtD
Meprobamate—Dermatitis—Epirubicin—pancreatic cancer	0.000284	0.00108	CcSEcCtD
Meprobamate—Headache—Epirubicin—pancreatic cancer	0.000282	0.00107	CcSEcCtD
Meprobamate—Dizziness—Doxorubicin—pancreatic cancer	0.000276	0.00105	CcSEcCtD
Meprobamate—Nausea—Epirubicin—pancreatic cancer	0.000268	0.00102	CcSEcCtD
Meprobamate—Vomiting—Doxorubicin—pancreatic cancer	0.000265	0.00101	CcSEcCtD
Meprobamate—Dermatitis—Doxorubicin—pancreatic cancer	0.000263	0.000997	CcSEcCtD
Meprobamate—Headache—Doxorubicin—pancreatic cancer	0.000261	0.000991	CcSEcCtD
Meprobamate—Nausea—Doxorubicin—pancreatic cancer	0.000248	0.00094	CcSEcCtD
